A medication that belongs to the thiazolidinedione (tzd) class of drugs, primarily used to manage type 2 diabetes.
An oral medication belonging to the sulfonylurea class, also used for managing type 2 diabetes.
Treatment of type 2 diabetes mellitus, particularly in patients whose blood sugar levels are not adequately controlled by diet and exercise alone.
Glimirep P1 Tab (Pioglitazone + Glimepiride) work together to lower blood sugar levels by different mechanisms: Pioglitazone: Increases insulin sensitivity by improving the body's response to insulin. This allows glucose to be absorbed by cells more effectively, thereby lowering blood sugar levels. Glimepiride: Stimulates the release of insulin from the pancreas. Insulin is a hormone that helps regulate blood sugar levels. By promoting insulin secretion, glimepiride helps to lower blood sugar levels.
Store the medication in a cool, dry place, away from direct sunlight and moisture. Keep it out of reach of children and pets.
The dosage of Pioglitazone + Glimepiride is individualized and determined by your doctor based on your specific condition and response to treatment.
It is typically taken once daily, with or without food.
Your doctor will guide you on the appropriate dose and how to take the medication.
Common side effects include:
Headache
Weight gain
Fluid retention (swelling)
Fatigue
Upper respiratory tract infections
Dizziness
Nausea
Vomiting
Diarrhea
Constipation
Rash
Itching
Liver problems (rare)
Heart failure (rare)
Alcohol can increase the risk of low blood sugar. Discuss alcohol consumption with your doctor.
This medication can cause dizziness or drowsiness. It is advisable to avoid driving or operating machinery until you know how this medication affects you.
This medication is not recommended during pregnancy or breastfeeding. Discuss with your doctor about alternative options.
Pioglitazone + Glimepiride is not indicated for use in children.
Caution is advised in patients with kidney problems.
This medication can cause liver problems. Your doctor may monitor your liver function during treatment.
Please consult your healthcare provider or pharmacist for more detailed information. This information is not a substitute for professional medical advice.
You can also find information about this medication on the official websites of the FDA (Food and Drug Administration) and the European Medicines Agency (EMA).
